BillionToOne, Inc. (NasdaqGS: BLLN)
Health Care · Health Care Providers & Services · US
$96.35
-3.72% today · -8.1% 1Y
BillionToOne, Inc. (NasdaqGS: BLLN) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $4.72B and employs 713 people.
Over the last twelve months the share price has lost 8.1%, trading between 61.96 and 150.44.
Tweenvest scores BillionToOne, Inc. across four factors: quality 52/100. Its strongest factor is quality.
BLLN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.72B
- Revenue (TTM)
- $397.41M
- P/E
- 130.13
- EPS
- 0.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $150.44
- 52-week low
- $61.96
- Avg volume (3M)
- —
- Shares outstanding
- 47.19M
- Employees
- 713
- Next earnings
- —
About BillionToOne, Inc.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
- ISIN
- US0901681058
- Founded
- 2016
- Listed since
- Nov 6, 2025
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $118.82B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $105.52B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $73.81B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.60B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.